Date published: 2026-5-30

1-800-457-3801

SCBT Portrait Logo
Seach Input

NPY4-R Inhibitors

NPY4-R inhibitors belong to a class of chemical compounds that target the NPY4 receptor, also known as the neuropeptide Y receptor type 4. These inhibitors play a crucial role in modulating the activity of the NPY4 receptor, which is a member of the neuropeptide Y (NPY) receptor family found in the central and peripheral nervous systems. The NPY4 receptor is a G-protein coupled receptor (GPCR) that is involved in regulating various physiological processes, including appetite regulation, energy homeostasis, and cardiovascular functions. NPY4-R inhibitors specifically interfere with the binding of neuropeptide Y and related peptides to the NPY4 receptor, thus altering its signaling pathway. NPY4-R inhibitors can vary widely in structure, but they generally possess properties that enable them to bind selectively to the NPY4 receptor. This selectivity is crucial for minimizing off-target effects and ensuring the specificity of their action. By inhibiting the NPY4 receptor, these compounds can potentially influence the release of neurotransmitters and hormones involved in the aforementioned physiological processes. As a result, they have garnered significant attention in the fields of neuroscience and pharmacology as potential tools for investigating the role of the NPY4 receptor in various biological functions. Researchers are actively exploring the molecular mechanisms by which NPY4-R inhibitors interact with the receptor and how these interactions impact downstream signaling pathways.
Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

BIIE 0246

246146-55-4sc-203530
sc-203530A
1 mg
10 mg
$321.00
$530.00
1
(1)

As a selective antagonist of the Y2 receptor, BIIE0246's inhibition of Y2 can affect the levels of Neuropeptide Y and its distribution, which could indirectly influence the signaling through the Y4 receptor.

LU AA33810

304008-29-5sc-295367
sc-295367A
10 mg
50 mg
$169.00
$638.00
(0)

Lu AA33810 is a Neuropeptide Y Y5 receptor antagonist. By blocking Y5 receptors, it may indirectly reduce the activation of the Y4 receptor by altering Neuropeptide Y signaling dynamics.

SF 11

443292-81-7sc-311535
sc-311535A
5 mg
25 mg
$105.00
$425.00
1
(0)

SF-11 is an antagonist of the Y1 receptor and could indirectly affect Y4 receptor signaling by competing for Neuropeptide Y, potentially influencing its activity on the Y4 receptor.